ALK-Abelló expands Catalent tablet partnership, investing DKK 500 million

ALK-Abelló A/S has expanded its contract manufacturing partnership with Catalent for Zydis fast-dissolving tablet technology, securing prioritized manufacturing capacity and lifting annual output by about 40% to 1.1 billion tablets from the early 2030s. ALK will commit about DKK 500 million over three years to fund capacity expansion at Catalent.